Disease ⇒ Immunotherapy-induced colitis {40000144}
Type: | Disease |
---|---|
Parent: | [ ] |
Definition: | Immunotherapy-induced colitis |
Initialisation date: | 0000-00-00 |
---|---|
Other Terms: | [ ] |
MedDra ID: | [ ] |
---|---|
MedDra Level: | [ ] |
ICD: | [ ] |
Category: | [ ] |
Zone: | [ ] |
Mechanism: | [ ] |
Notes:
[ ]
Shared Reference Notes
- [1.1]
- Dietary prebiotics, which can be metabolized by bacteria to produce #Butyrate, can be an intriguing new investigational approach to prevent immunotherapy-induced colitis and lead to improved patient outcomes. - #Butyrate is a gut-microbiome-derived, anti-inflammatory metabolite that could be protective against ICI colitis, based on data from other forms of colitis. - #Dietary prebiotic starches that can increase #Butyrate production are a promising method of microbial manipulation that could be used to mitigate ICI colitis.
References Notes
[ ]